Advanced search
Publication Cover
Substance Abuse Volume 39, 2018 - Issue 3
Journal homepage
415
Views
32
CrossRef citations to date
0
Altmetric
Brief Report

Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration

Helen Valenstein-MahCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System, Minneapolis, Minnesota, USA; ;Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-5726-2026View further author information
, PhD ORCID Icon,
Hildi HagedornCenter for Chronic Disease Outcomes Research, Minneapolis VA Healthcare System, Minneapolis, Minnesota, USA; ;Department of Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota, USA; View further author information
, PhD,
Chad L. KayAcademic Detailing Service, Pharmacy Benefits Management, VA Central Office, Washington, DC, USA; View further author information
, PharmD,
Melissa L. ChristopherAcademic Detailing Service, Pharmacy Benefits Management, VA Central Office, Washington, DC, USA; View further author information
, PharmD &
Adam J. GordonInformatics, Decision-Enhancement and Analytic Sciences Center (IDEAS2) and Vulnerable Veteran–Innovative PACT (VIP) Initiative, Salt Lake City VA Health Care System, Salt, Lake City, Utah, USA; ;Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA; ;Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, Utah, USAORCID Iconhttp://orcid.org/0000-0002-2453-8871View further author information
, MD, MPH ORCID Icon
Pages 286-288 | Received 27 Jul 2018, Accepted 31 Jul 2018, Published online: 16 Oct 2018

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Jennifer Pustz, Shikhar Shrestha, Sarah Newsky, Melissa Taylor, Leslie Fowler, Michelle Van Handel, Cailyn Lingwall & Thomas J. Stopka. (2022) Opioid-Involved Overdose Vulnerability in Wyoming: Measuring Risk in a Rural Environment. Substance Use & Misuse 57:11, pages 1720-1731.
Read now
Elly Riser, Leigh Ann Holterman, Sanchit Maruti, John R. Brooklyn, Stephen G. DeVoe, Bradley J. Tompkins, Jacqueline Drouin & Halle G. Sobel. (2021) Integrating DATA 2000 waiver training into undergraduate medical education: The time is now. Substance Abuse 42:2, pages 236-243.
Read now
Adam J. Gordon, Karen Drexler, Eric J. Hawkins, Jennifer Burden, Nodira K. Codell, Amy Mhatre-Owens, Matthew T. Dungan & Hildi Hagedorn. (2020) Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse 41:3, pages 275-282.
Read now
Ajay Manhapra, Elina Stefanovics & Robert Rosenheck. (2020) Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?. Substance Abuse 41:1, pages 110-120.
Read now
Joseph W. Frank, Sarah E. Wakeman & Adam J. Gordon. (2018) No end to the crisis without an end to the waiver. Substance Abuse 39:3, pages 263-265.
Read now

Articles from other publishers (27)

Sarah Cercone Heavey, Gregory P. Beehler & Jennifer Funderburk. (2024) (RE-)AIMing for Rapid Uptake. Medical Care 62:1, pages 44-51.
Crossref
Michael A. Incze, David Chen, Patrick Galyean, Elisabeth R. Kimball, Laura Stolebarger, Susan Zickmund & Adam J. Gordon. (2023) Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study. Journal of Addiction Medicine 17:4, pages 401-406.
Crossref
C. Greer McCollum, Ellen Eaton, Thomas Creger, Aaron Lee, Kelly Gagnon & Li Li. (2023) Physicians’ experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder. Drug and Alcohol Dependence 244, pages 109777.
Crossref
Rachel K. Landis, Isaac Opper, Brendan Saloner, Adam J. Gordon, Douglas L. Leslie, Mark Sorbero & Bradley D. Stein. (2022) Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies. Drug and Alcohol Dependence 241, pages 109669.
Crossref
Lewei (Allison) Lin, Victoria D. Powell, Colin Macleod, Amy S.B. Bohnert & Pooja Lagisetty. (2022) Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder. Journal of Substance Abuse Treatment 141, pages 108827.
Crossref
Jayamalathi Priyanka Vakkalanka, Brian C. Lund, Stephan Arndt, William Field, Mary Charlton, Marcia M. Ward & Ryan M. Carnahan. (2021) Therapeutic relationships between Veterans and buprenorphine providers and effects on treatment retention. Health Services Research 57:2, pages 392-402.
Crossref
Ashley O. Radmall, Spencer Calder, Nodira Codell, Alan Taylor Kelley, Eric Hawkins, Audrey L. Jones, Hildi J. Hagedorn, Mary Anne Reynolds & Adam J. Gordon. (2022) Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of Addictions Nursing 33:2, pages 70-79.
Crossref
Adam J. Gordon, Marie Kenny, Matthew Dungan, Allison M. Gustavson, A. Taylor Kelley, Audrey L. Jones, Eric Hawkins, Joseph W. Frank, Anissa Danner, Joseph Liberto & Hildi Hagedorn. (2022) Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings. The American Journal on Addictions 31:2, pages 152-158.
Crossref
Jessica J. Wyse, Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Amy J. Kennedy, Benjamin J. Oldfield, Julie R. Gaither, Kirsha S. Gordon, Melissa Skanderson, Declan T. Barry, Kendall Bryant, Stephen Crystal, Amy C. Justice & Kevin L. Kraemer. (2021) Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS and Behavior 26:3, pages 975-985.
Crossref
Amy J. Kennedy, Kathleen A. McGinnis, Jessica S. Merlin, E. Jennifer Edelman, Adam J. Gordon, P. Todd Korthuis, Melissa Skanderson, Emily C. Williams, Jessica Wyse, Benjamin Oldfield, Kendall Bryant, Amy Justice, David A. Fiellin & Kevin L. Kraemer. (2022) Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of Substance Abuse Treatment 132, pages 108509.
Crossref
Allison M. Gustavson, Jennifer P. Wisdom, Marie E. Kenny, Hope A. Salameh, Princess E. Ackland, Barbara Clothier, Siamak Noorbaloochi, Adam J. Gordon & Hildi J. Hagedorn. (2021) Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implementation Science Communications 2:1.
Crossref
Allison M. Gustavson, Marie E. Kenny, Jennifer P. Wisdom, Hope A. Salameh, Princess E. Ackland, Adam J. Gordon & Hildi J. Hagedorn. (2021) Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addiction Science & Clinical Practice 16:1.
Crossref
Matthew R. Filteau, Brandn Green & Kristal Jones. (2021) Barriers to Community Treatment for Opioid Use Disorders among Rural Veterans. Journal of Veterans Studies 7:3, pages 83.
Crossref
Irineo Cabreros, Beth Ann Griffin, Brendan Saloner, Adam J. Gordon, Rose Kerber & Bradley D. Stein. (2021) Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories. Drug and Alcohol Dependence 228, pages 109089.
Crossref
Jacob D. Armstrong, Amy Bauman, Krystal J. Moroney & C. Brendan Clark. 2021. Addictions - Diagnosis and Treatment. Addictions - Diagnosis and Treatment.
Justin C. Strickland, Andrew S. Huhn, Cecilia L. Bergeria, Eric C. Strain & Kelly E. Dunn. (2021) Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D. Journal of Addiction Medicine 15:4, pages 325-333.
Crossref
Michael Fairley, Keith Humphreys, Vilija R. Joyce, Mark Bounthavong, Jodie Trafton, Ann Combs, Elizabeth M. Oliva, Jeremy D. Goldhaber-Fiebert, Steven M. Asch, Margaret L. Brandeau & Douglas K. Owens. (2021) Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA Psychiatry 78:7, pages 767.
Crossref
Lindsay M. Mailloux, Matthew T. Haas, Janel M. Larew & Beth M. DeJongh. (2021) Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone. Mental Health Clinician 11:1, pages 35-39.
Crossref
Lewei A. Lin, Amy S. B. Bohnert, Frederic C. Blow, Adam J. Gordon, Rosalinda V. Ignacio, H. Myra Kim & Mark A. Ilgen. (2020) Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction 116:1, pages 96-104.
Crossref
Evelyn T. Chang, Rebecca S. Oberman, Amy N. Cohen, Stephanie L. Taylor, Elisa Gumm, Aram S. Mardian, Shawn Toy, Araceli Revote, Britney Lewkowitz & Elizabeth M. Yano. (2020) Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care. Journal of General Internal Medicine 35:S3, pages 918-926.
Crossref
Jennifer Jones, Matthew Tierney, Gabrielle Jacobs, Shao-Yun Chien & Sandra Mallisham. (2020) Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. Journal of Addictions Nursing 31:4, pages 261-268.
Crossref
Scott E. Hadland, Victoria A. Jent, Rachel H. Alinsky, Brandon D.L. Marshall, Pia M. Mauro & Magdalena Cerdá. (2020) Opioid Use Disorder Treatment Facilities With Programs for Special Populations. American Journal of Preventive Medicine 59:3, pages e125-e133.
Crossref
Audrey L. Jones, Stefan G. Kertesz, Leslie R.M. Hausmann, Maria K. Mor, Ying Suo, Warren B.P. Pettey, James H. SchaeferJrJr, Adi V. Gundlapalli & Adam J. Gordon. (2020) Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of Substance Abuse Treatment 113, pages 107996.
Crossref
Utibe R. Essien, Florentina E. Sileanu, Xinhua Zhao, Jane M. Liebschutz, Carolyn T. Thorpe, Chester B. Good, Maria K. Mor, Thomas R. Radomski, Leslie R. M. Hausmann, Michael J. Fine & Walid F. Gellad. (2020) Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of General Internal Medicine 35:5, pages 1537-1544.
Crossref
Alex J. Luli, Mark Bounthavong & Jonathan H. Watanabe. (2020) Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder. Journal of the American Pharmacists Association 60:2, pages 297-303.
Crossref
Amanda J. Abraham, Christina M. Andrews, Samantha J. Harris & Peter D. Friedmann. (2020) Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA. Neurotherapeutics 17:1, pages 55-69.
Crossref
Jennifer L Koehl, David E Zimmerman & Patrick J Bridgeman. (2019) Medications for management of opioid use disorder. American Journal of Health-System Pharmacy 76:15, pages 1097-1103.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.